CNRS, Génétique Moléculaire et Défense Antivirale, Centre Universitaire des Saints-Pères, Université Paris Descartes, 75006 Paris, France.
Anal Chem. 2013 Apr 2;85(7):3765-73. doi: 10.1021/ac400038b. Epub 2013 Mar 21.
Huntington's disease is caused by a polyglutamine expansion in huntingtin. Affected brain regions contain characteristic aggregates of the misfolded expanded protein. Studies in cells and animals show that aggregates are polymorphic and that the secondary structure of the aggregates is likely to condition their cytotoxicity. Therefore knowing the structure of aggregates is important as neurotoxic secondary structures may be specifically targeted during the search for prophylactic or therapeutic drugs. The structure of aggregates in the brain of patients is still unknown. Using synchrotron based infrared microspectroscopy we demonstrate that the brains of patients with Huntington disease contain putative oligomers and various kinds of microscopic aggregates (inclusions) that can be distinguished by their differential absorbance at 1627 cm(-1) (amyloid β sheets) and 1639 cm(-1) (β sheets/unordered). We also describe the parallel/antiparallel organization of the β strands. As the inclusions enriched in both β sheets and β sheets/unordered structures are characteristic of severely affected brain regions, we conclude that this kind of amyloid inclusions is likely to be particularly toxic to neurons.
亨廷顿病是由亨廷顿蛋白中的多聚谷氨酰胺扩展引起的。受影响的大脑区域包含错误折叠扩展蛋白的特征性聚集物。细胞和动物研究表明,聚集物是多态的,聚集物的二级结构可能影响其细胞毒性。因此,了解聚集物的结构很重要,因为在寻找预防或治疗药物时,可能会针对神经毒性二级结构进行特异性靶向。患者大脑中的聚集物结构仍不清楚。我们使用基于同步加速器的红外微光谱技术证明,亨廷顿病患者的大脑中含有假定的低聚物和各种微观聚集物(包含物),可以通过在 1627cm(-1)(淀粉样β片层)和 1639cm(-1)(β片层/无定形)处的差异吸收来区分。我们还描述了β链的平行/反平行组织。由于富含β片层和β片层/无定形结构的包含物是受严重影响的大脑区域的特征,因此我们得出结论,这种淀粉样包含物可能对神经元特别有毒。